The DOI matches its Crossref record.
Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations
Abstract
In the 1966 study of the population of Busselton, Australia, blood sugar and serum insulin levels were measured one hour after an oral glucose load, in addition to the conventional cardiovascular risk factors. The six-year incidence of coronary heart disease (CHD) and the 12-yr mortality from CHD and from all cardiovascular diseases is described in relation to the initial baseline variables measured using the upper 20th percentile values (age-specific and sex-specific) to define the risk ratios. In younger subjects (ages less than 60 yr), elevated blood pressure levels for both sexes (risk ratios from 2.9 to 5.2) and elevated serum cholesterol concentrations for males (risk ratios from 3.0 to 3.3) were strong predictors of cardiovascular risk. In men aged 60 to 69 yr, those with upper range one-hour serum insulin concentrations showed marked associations with the six-year incidence of CHD, the 12-yr mortality from CHD, and the 12-yr mortality from all cardiovascular diseases (risk ratios were 2.0, 2.3, and 2.4, respectively). The relationship of elevated serum insulin and cardiovascular mortality persisted when males of all ages were analyzed, and it appeared to be independent of the other major risk factors. In females, no association between serum insulin and CHD or cardiovascular disease could be found. Although the age and sex specific upper 20th percentile values for one-hour blood sugar concentrations showed a low grade association in patients with subsequent cardiovascular disease end points, more noticeable risk ratios were demonstrated at the higher blood sugar level of 200 mg/100 ml or greater (in the age group 60 yr and over, risk ratios were 2.2 in males and 2.6 in females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Human Aging: Usual and Successful
Rowe, J. W., & Kahn, R. L. (1987) · Science · doi:10.1126/science.3299702 · Cited by 3,384
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Diabetes and atherosclerosis: An epidemiologic view
Pyörälä, K., Laakso, M., & Uusitupa, M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 919
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN
Donahue, R., & Abbott, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91357-2 · Cited by 818
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
Mullarkey, C. J., Edelstein, D., & Brownlee, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80875-7 · Cited by 690
Is visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Hanley, A. J. G., Williams, K., Stern, M. P., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1177 · Cited by 637
Fontbonne, A., Eschw�ge, E., Cambien, F., Richard, J. L., Ducimeti�re, P., Thibult, N., Warnet, J. M., Claude, J. R., & Rosselin, G. E. (1989) · Diabetologia · doi:10.1007/bf00265546 · Cited by 617
Microalbuminuria as predictor of increased mortality in elderly people.
Damsgaard, E. M., Frøland, A., Jørgensen, O. D., & Mogensen, C. E. (1990) · BMJ · doi:10.1136/bmj.300.6720.297 · Cited by 609
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Diabetes mellitus and hypertension.
Epstein, M., & Sowers, J. R. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.403 · Cited by 600
Salomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
The Diabetes Prevention Program Research Group (2005) · Diabetes Care · doi:10.2337/diacare.28.4.888 · Cited by 572
Juhan-Vague, I., Alessi, M. C., & Vague, P. (1991) · Diabetologia · doi:10.1007/bf00403280 · Cited by 567
SACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
Insulin Resistance and Cardiovascular Disease1
McFarlane, S. I., Banerji, M., & Sowers, J. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7202 · Cited by 501
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492
Ascaso, J. F., Pardo, S., Real, J. T., Lorente, R. I., Priego, A., & Carmena, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3320 · Cited by 490
Ferrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451
Jarrett, R. J., McCartney, P., & Keen, H. (1982) · Diabetologia · doi:10.1007/bf00254833 · Cited by 436
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
Conway, G. S., Agrawal, R., Betteridge, D. J., & Jacobs, H. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02295.x · Cited by 427
George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.
Bierman, E. L. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.647 · Cited by 413
Bauman, W. A., & Spungen, A. M. (1994) · Metabolism · doi:10.1016/0026-0495(94)90126-0 · Cited by 404
Bao, W. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420160079011 · Cited by 404
The Associations between Obesity, Adipose Tissue Distribution and Disease
BJÖRNTORP, P. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb05935.x · Cited by 403
Insulin and Risk of Cardiovascular Disease: A Meta-Analysis
Ruige, J. B., Assendelft, W. J. J., Dekker, J. M., Kostense, P. J., Heine, R. J., & Bouter, L. M. (1998) · Circulation · doi:10.1161/01.cir.97.10.996 · Cited by 391
Development of the Multiple Metabolic Syndrome: An Epidemiologic Perspective
Liese, A. D., Mayer-Davis, E. J., & Haffner, S. M. (1998) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017978 · Cited by 380
Fontbonne, A., Charles, M. A., Thibult, N., Richard, J. L., Claude, J. R., Warnet, J. M., Rosselin, G. E., & Eschw�ge, E. (1991) · Diabetologia · doi:10.1007/bf00405009 · Cited by 377
Shinohara, K., Shoji, T., Emoto, M., Tahara, H., Koyama, H., Ishimura, E., Miki, T., Tabata, T., & Nishizawa, Y. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019900.87535.43 · Cited by 377
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 376
Pyörälä, K., Savolainen, E., Kaukola, S., & Haapakoski, J. (1985) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1985.tb08888.x · Cited by 364
Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease
Yip, J. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2773 · Cited by 360
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease
DiNicolantonio, J. J., Lucan, S. C., & O’Keefe, J. H. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.11.006 · Cited by 354
Prognostic value of the metabolic syndrome in essential hypertension
Schillaci, G., Pirro, M., Vaudo, G., Gemelli, F., Marchesi, S., Porcellati, C., & Mannarino, E. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.049 · Cited by 352
Pyörälä, M., Miettinen, H., Laakso, M., & Pyörälä, K. (1998) · Circulation · doi:10.1161/01.cir.98.5.398 · Cited by 349
CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN
Donahue, R., Bloom, E., Abbott, R., Reed, D., & Yano, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91605-9 · Cited by 348
Kiechl, S., Willeit, J., Poewe, W., Egger, G., Oberhollenzer, F., Muggeo, M., & Bonora, E. (1996) · BMJ · doi:10.1136/bmj.313.7064.1040 · Cited by 346
Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L., & Smith, U. (1990) · Metabolism · doi:10.1016/0026-0495(90)90164-8 · Cited by 342
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Stern, M. P., & Haffner, S. M. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.123 · Cited by 331
Insulin resistance in type 2 diabetes: role of fatty acids
Arner, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.254 · Cited by 323
Juhan-Vague, I., Thompson, S. G., & Jespersen, J. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1865 · Cited by 322
Insulin resistance is a cardiovascular risk factor in humans
Adeva-Andany, M. M., Martínez-Rodríguez, J., González-Lucán, M., Fernández-Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 313
Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men
Lempiäinen, P., Mykkänen, L., Pyörälä, K., Laakso, M., & Kuusisto, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.123 · Cited by 293
Janssen, J. A. M. J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157797 · Cited by 294
A ROLE FOR INSULIN IN THE AETIOLOGY AND COURSE OF HYPERTENSION?
Reaven, G., & Hoffman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90968-8 · Cited by 292
LAWS, A., & REAVEN, G. M. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00494.x · Cited by 291
Uusitupa, M. I., Niskanen, L. K., Siitonen, O., Voutilainen, E., & Pyörälä, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 291
Alessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J., & Collen, D. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646997 · Cited by 289
Juhan-Vague, I., Roul, C., Alessi, M. C., Ardissone, J. P., Heim, M., & Vague, P. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646598 · Cited by 289
Laakso, M., Sarlund, H., & Mykkänen, L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.223 · Cited by 286
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Diabetes as an atherogenic factor
Ruderman, N. B., & Haudenschild, C. (1984) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(84)90011-2 · Cited by 282
Insulin resistance and risk for stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., & Horwitz, R. I. (2002) · Neurology · doi:10.1212/wnl.59.6.809 · Cited by 280
Orio, F., Palomba, S., Spinelli, L., Cascella, T., Tauchmanovà, L., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032049 · Cited by 275
Haffner, S. M., Stern, M. P., Gruber, M. K., Hazuda, H. P., Mitchell, B. D., & Patterson, J. K. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.727 · Cited by 266
The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?
Nathan, D. M., Meigs, J., & Singer, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90021-0 · Cited by 265
Insulin-induced vasodilatation: physiology or pharmacology?
Yki-Järvinen, H., & Utriainen, T. (1998) · Diabetologia · doi:10.1007/s001250050919 · Cited by 261
Effects of Endurance Training on Glucose Tolerance and Plasma Lipid Levels in Older Men and Women
Seals, D. R. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350050033022 · Cited by 261
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Ferrannini, E., & DeFronzo, R. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv239 · Cited by 258
Bao, W., Srinivasan, S. R., & Berenson, G. S. (1996) · Circulation · doi:10.1161/01.cir.93.1.54 · Cited by 257
Reaven, G. M. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90434-j · Cited by 252
Insulin resistance and coronary artery disease
Bressler, P., Bailey, S. R., Matsuda, M., & DeFronzo, R. A. (1996) · Diabetologia · doi:10.1007/s001250050581 · Cited by 226
Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects
Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00429.x · Cited by 211
Nagi, D. K., Hendra, T. J., Ryle, A. J., Cooper, T. M., Temple, R. C., Clark, P. M. S., Schneider, A. E., Hales, C. N., & Yudkin, J. S. (1990) · Diabetologia · doi:10.1007/bf00404140 · Cited by 198
Sarwar, N., Aspelund, T., Eiriksdottir, G., Gobin, R., Seshasai, S. R. K., Forouhi, N. G., Sigurdsson, G., Danesh, J., & Gudnason, V. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000278 · Cited by 175
Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study
Simon, D., Preziosi, P., Barrett-Connor, E., Roger, M., Saint-Paul, M., Nahoul, K., & Papoz, L. (1992) · Diabetologia · doi:10.1007/bf00402551 · Cited by 157
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Neurology · doi:10.1212/01.wnl.0000063318.66140.a3 · Cited by 126
Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?
Stern, M. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00006 · Cited by 115
Bozorgmanesh, M., Hadaegh, F., & Azizi, F. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-100 · Cited by 81
The Role of the Autonomic Nervous System in Hypertension.
Amerena, J., & Julius, S. (1995) · Hypertension Research · doi:10.1291/hypres.18.99 · Cited by 63
Metadata
- Authors
- Welborn, T. A., & Wearne, K.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1979-03-01
- Volume
- 2
- Issue
- 2
- Pages
- 154-160
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2085507845
- Cited by
- 735
- References
- 0
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.